Nucleolar aggresomes as counterparts of cytoplasmic aggresomes in proteotoxic stress

BioEssays

Volumn 33, Issue 5, 2011, Pages 386-395

  Latonen, Leena ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aggresome; Cancer; Inclusion diseases; Neurodegeneration; Nucleolus; Ubiquitin proteasome system

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; DNA DIRECTED RNA POLYMERASE; EXPORTIN 1; HEAT SHOCK PROTEIN; LEPTOMYCIN B; LEUPEPTIN; MAX PROTEIN; MITOCHONDRIAL PROTEIN; NUCLEAR PROTEIN; POLYADENYLATED RNA; PROTEASOME INHIBITOR; PROTEIN MDM2; PROTEIN P21; PROTEIN P27; PROTEIN P53; RIBONUCLEOPROTEIN; RIBOSOME RNA; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; UBIQUITIN;

AGGRESOME; CELL MIGRATION; CELL STRESS; CELLULAR STRESS RESPONSE; DEGENERATIVE DISEASE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FIBROBLAST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUNTINGTON CHOREA; MULTIPLE MYELOMA; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEOLUS; PROTEIN AGGREGATION; PROTEIN DEGRADATION; REVIEW; RNA PROCESSING; RNA TRANSCRIPTION; RNA TRANSPORT; SIGNAL TRANSDUCTION; SOLID TUMOR;

ANIMALS; CELL NUCLEUS; CYTOPLASM; HUMANS; INCLUSION BODIES; NEOPLASMS; NEURODEGENERATIVE DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; RIBONUCLEOPROTEINS;

EID: 79954807086     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100008     Document Type: Review

References (102)

1. Goldberg AL. 2007. Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy. Biochem Soc Trans 35: 12-7.
2. Navon A, Ciechanover A. 2009. The 26 S proteasome: from basic mechanisms to drug targeting. J Biol Chem 284: 33713-8.
3. Tsvetkov P, Asher G, Paz A, Reuven N, et al. 2008. Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome. Proteins 70: 1357-66.
4. Ma CP, Slaughter CA, DeMartino GN. 1992. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem 267: 10515-23.
5. Mosesson Y, Yarden Y. 2006. Monoubiquitylation: a recurrent theme in membrane protein transport. Isr Med Assoc J 8: 233-7.
6. Salmena L, Pandolfi PP. 2007. Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. Nat Rev Cancer 7: 409-13.
7. Ikeda F, Dikic I. 2008. Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep 9: 536-42.
8. Saeki Y, Kudo T, Sone T, Kikuchi Y, et al. 2009. Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J 28: 359-71.
9. Xu P, Duong DM, Seyfried NT, Cheng D, et al. 2009. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137: 133-45.
10. Chen ZJ, Sun LJ. 2009. Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33: 275-86.
11. Reyes-Turcu FE, Wilkinson KD. 2009. Polyubiquitin binding and disassembly by deubiquitinating enzymes. Chem Rev 109: 1495-508.
12. Wójcik C, DeMartino GN. 2003. Intracellular localization of proteasomes. Int J Biochem Cell Biol 35: 579-89.
13. Goldberg AL. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-9.
14. Lehman NL. 2009. The ubiquitin proteasome system in neuropathology. Acta Neuropathol 118: 329-47.
15. Huang Q, Figueiredo-Pereira ME. 2010. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis 15: 1292-311.
16. Johnston JA, Ward CL, Kopito RR. 1998. Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143: 1883-98.
17. Holmberg CI, Illman SA, Kallio M, Mikhailov A, et al. 2000. Formation of nuclear HSF1 granules varies depending on stress stimuli. Cell Stress Chaperones 5: 219-28.
18. Latonen L, Moore HM, Bai B, Jäämaa S, et al. 2011. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability. Oncogene 30: 790-805.
19. Kisselev AF, Goldberg AL. 2001. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8: 739-58.
20. Hernandez-Verdun D. 2006. Nucleolus: from structure to dynamics. Histochem Cell Biol 125: 127-37.
21. Boisvert FM, van Koningsbruggen S, Navascués J, Lamond AI. 2007. The multifunctional nucleolus. Nat Rev Mol Cell Biol 8: 574-85.
22. Sirri V, Urcuqui-Inchima S, Roussel P, Hernandez-Verdun D. 2008. Nucleolus: the fascinating nuclear body. Histochem Cell Biol 129: 13-31.
23. Andersen JS, Lam YW, Leung AK, Ong SE, et al. 2005. Nucleolar proteome dynamics. Nature 433: 77-83.
24. Boulon S, Westman BJ, Hutten S, Boisvert FM, et al. 2010. The nucleolus under stress. Mol Cell 40: 216-27.
25. Mimnaugh EG, Xu W, Vos M, Yuan X, et al. 2004. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol Cancer Ther 3: 551-66.
26. Klibanov SA, O'Hagan HM, Ljungman M. 2001. Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. J Cell Sci 114: 1867-73.
27. Mattsson K, Pokrovskaja K, Kiss C, Klein G, et al. 2001. Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc Natl Acad Sci USA 98: 1012-7.
28. Xirodimas D, Saville MK, Edling C, Lane DP, et al. 2001. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20: 4972-83.
29. Latonen L, Kurki S, Pitkänen K, Laiho M. 2003. p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction. Cell Signal 15: 95-102.
30. Karni-Schmidt O, Friedler A, Zupnick A, McKinney K, et al. 2007. Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene 26: 3878-91.
31. Krüger T, Scheer U. 2010. p53 localizes to intranucleolar regions distinct from the ribosome production compartments. J Cell Sci 123: 1203-8.
32. Kurki S, Peltonen K, Laiho M. 2004. Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response. Cell Cycle 3: 976-9.
33. Rockel TD, Stuhlmann D, von Mikecz A. 2005. Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J Cell Sci 118: 5231-42.
34. Arabi A, Rustum C, Hallberg E, Wright AP. 2003. Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels. J Cell Sci 116: 1707-17.
35. Scharf A, Rockel TD, von Mikecz A. 2007. Localization of proteasomes and proteasomal proteolysis in the mammalian interphase cell nucleus by systematic application of immunocytochemistry. Histochem Cell Biol 127: 591-601.
36. Karni-Schmidt O, Zupnick A, Castillo M, Ahmed A, et al. 2008. p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner. J Cell Sci 121: 4098-105.
37. Lam YW, Lamond AI, Mann M, Andersen JS. 2007. Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr Biol 17: 749-60.
38. Millevoi S, Vagner S. 2010. Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation. Nucleic Acids Res 38: 2757-74.
39. Hutten S, Kehlenbach RH. 2007. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol 17: 193-201.
40. O'Hagan HM, Ljungman M. 2004. Efficient NES-dependent protein nuclear export requires ongoing synthesis and export of mRNAs. Exp Cell Res 297: 548-59.
41. Kadowaki T, Hitomi M, Chen S, Tartakoff AM. 1994. Nuclear mRNA accumulation causes nucleolar fragmentation in yeast mtr2 mutant. Mol Biol Cell 5: 1253-63.
42. Thomsen R, Saguez C, Nasser T, Jensen TH. 2008. General, rapid, and transcription-dependent fragmentation of nucleolar antigens in S. cerevisiae mRNA export mutants. RNA 14: 706-16.
43. Houseley J, Tollervey D. 2009. The many pathways of RNA degradation. Cell 136: 763-76.
44. Slomovic S, Laufer D, Geiger D, Schuster G. 2006. Polyadenylation of ribosomal RNA in human cells. Nucleic Acids Res 34: 2966-75.
45. West S, Gromak N, Norbury CJ, Proudfoot NJ. 2006. Adenylation and exosome-mediated degradation of cotranscriptionally cleaved pre-messenger RNA in human cells. Mol Cell 21: 437-43.
46. Fujii K, Kitabatake M, Sakata T, Miyata A, et al. 2009. A role for ubiquitin in the clearance of nonfunctional rRNAs. Genes Dev 23: 963-74.
47. Dez C, Houseley J, Tollervey D. 2006. Surveillance of nuclear-restricted pre-ribosomes within a subnucleolar region of Saccharomyces cerevisiae EMBO J 25: 1534-46.
48. Carneiro T, Carvalho C, Braga J, Rino J, et al. 2007. Depletion of the yeast nuclear exosome subunit Rrp6 results in accumulation of polyadenylated RNAs in a discrete domain within the nucleolus. Mol Cell Biol 27: 4157-65.
49. Stavreva DA, Kawasaki M, Dundr M, Koberna K, et al. 2006. Potential roles for ubiquitin and the proteasome during ribosome biogenesis. Mol Cell Biol 26: 5131-45.
50. Spence J, Gali RR, Dittmar G, Sherman F, et al. 2000. Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain. Cell 102: 67-76.
51. Peng J, Schwartz D, Elias JE, Thoreen CC, et al. 2003. A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 21: 921-6.
52. Sudha T, Tsuji H, Sameshima M, Matsuda Y, et al. 1995. Abnormal integrity of the nucleolus associated with cell cycle arrest owing to the temperature-sensitive ubiquitin-activating enzyme E1. Chromosome Res 3: 115-23.
53. Matafora V, D'Amato A, Mori S, Blasi F, et al. 2009. Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. Mol Cell Proteomics 8: 2243-55.
54. Li M, Brooks CL, Wu-Baer F, Chen D, et al. 2003. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302: 1972-5.
55. Sherr CJ, Weber JD. 2000. The ARF/p53 pathway. Curr Opin Genet Dev 10: 94-9.
56. Rubbi CP, Milner J. 2003. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 22: 6068-77.
57. Lee JT, Gu W. 2010. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 17: 86-92.
58. Shirangi TR, Zaika A, Moll UM. 2002. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage. FASEB J 16: 420-2.
59. Abella N, Brun S, Calvo M, Tapia O, et al. 2010. Nucleolar disruption ensures nuclear accumulation of p21 upon DNA damage. Traffic 11: 743-55.
60. Castanotto D, Lingeman R, Riggs AD, Rossi JJ. 2009. CRM1 mediates nuclear-cytoplasmic shuttling of mature microRNAs. Proc Natl Acad Sci USA 106: 21655-9.
61. Boulon S, Verheggen C, Jady BE, Girard C, et al. 2004. PHAX and CRM1 are required sequentially to transport U3 snoRNA to nucleoli. Mol Cell 16: 777-87.
62. Thomas F, Kutay U. 2003. Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway. J Cell Sci 116: 2409-19.
63. Fornerod M, van Deursen J, van Baal S, Reynolds A, et al. 1997. The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88. EMBO J 16: 807-16.
64. Daelemans D, Costes SV, Lockett S, Pavlakis GN. 2005. Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo. Mol Cell Biol 25: 728-39.
65. Ernoult-Lange M, Wilczynska A, Harper M, Aigueperse C, et al. 2009. Nucleocytoplasmic traffic of CPEB1 and accumulation in Crm1 nucleolar bodies. Mol Biol Cell 20: 176-87.
66. Baydoun HH, Bellon M, Nicot C. 2008. HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking. AIDS Rev 10: 195-204.
67. Boyne JR, Whitehouse A. 2006. Nucleolar trafficking is essential for nuclear export of intronless herpesvirus mRNA. Proc Natl Acad Sci USA 103: 15190-5.
68. Boyne JR, Whitehouse A. 2009. Nucleolar disruption impairs Kaposi's sarcoma-associated herpesvirus ORF57-mediated nuclear export of intronless viral mRNAs. FEBS Lett 583: 3549-56.
69. Hu J, Cai XF, Yan G. 2009. Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation and nucleolar translocation of p21WAF1/CIP1 protein. Cell Cycle 8: 3328-39.
70. Dorval V, Fraser PE. 2007. SUMO on the road to neurodegeneration. Biochim Biophys Acta 1773: 694-706.
71. Zuccato C, Valenza M, Cattaneo E. 2010. Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev 90: 905-81.
72. Davies SW, Turmaine M, Cozens BA, DiFiglia M, et al. 1997. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90: 537-48.
73. Garyali P, Siwach P, Singh PK, Puri R, et al. 2009. The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system. Hum Mol Genet 18: 688-700.
74. Ganesh S, Puri R, Singh S, Mittal S, et al. 2006. Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy. J Hum Genet 51: 1-8.
75. Rudnicki DD, Holmes SE, Lin MW, Thornton CA, et al. 2007. Huntington's disease-like 2 is associated with CUG repeat-containing RNA foci. Ann Neurol 61: 272-82.
76. Schoser B, Timchenko L. 2010. Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. Curr Genomics 11: 77-90.
77. Yue S, Serra HG, Zoghbi HY, Orr HT. 2001. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. Hum Mol Genet 10: 25-30.
78. Irwin S, Vandelft M, Pinchev D, Howell JL, et al. 2005. RNA association and nucleocytoplasmic shuttling by ataxin-1. J Cell Sci 118: 233-42.
79. Kaytor MD, Duvick LA, Skinner PJ, Koob MD, et al. 1999. Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7. Hum Mol Genet 8: 1657-64.
80. Bowman AB, Yoo SY, Dantuma NP, Zoghbi HY. 2005. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet 14: 679-91.
81. Chen IC, Lin HY, Lee GC, Kao SH, et al. 2009. Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci. BMC Mol Biol 10: 9.
82. Sato N, Amino T, Kobayashi K, Asakawa S, et al. 2009. Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n. Am J Hum Genet 85: 544-57.
83. White MC, Gao R, Xu W, Mandal SM, et al. 2010. Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10. PLoS Genet 6: e1000984.
84. Li LB, Yu Z, Teng X, Bonini NM. 2008. RNA toxicity is a component of ataxin-3 degeneration in Drosophila Nature 453: 1107-11.
85. van Koningsbruggen S, Straasheijm KR, Sterrenburg E, de Graaf N, et al. 2007. FRG1P-mediated aggregation of proteins involved in pre-mRNA processing. Chromosoma 116: 53-64.
86. Calado A, Tomé FM, Brais B, Rouleau GA, et al. 2000. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet 9: 2321-8.
87. Berciano MT, Villagra NT, Ojeda JL, Navascues J, et al. 2004. Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus. Hum Mol Genet 13: 829-38.
88. Mittal S, Dubey D, Yamakawa K, Ganesh S. 2007. Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment. Hum Mol Genet 16: 753-62.
89. Pokrovskaja K, Mattsson K, Kashuba E, Klein G, et al. 2001. Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5. J Gen Virol 82: 345-58.
90. Ardley HC, Scott GB, Rose SA, Tan NG, et al. 2004. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease. J Neurochem 90: 379-91.
91. Mishra A, Godavarthi SK, Maheshwari M, Goswami A, et al. 2009. The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins. J Biol Chem 284: 10537-45.
92. Chatterjee TK, Fisher RA. 2003. Mild heat and proteotoxic stress promote unique subcellular trafficking and nucleolar accumulation of RGS6 and other RGS proteins. Role of the RGS domain in stress-induced trafficking of RGS proteins. J Biol Chem 278: 30272-82.
93. Le Goff P, Le Dréan Y, Le Péron C, Le Jossic-Corcos C, et al. 2004. Intracellular trafficking of heat shock factor 2. Exp Cell Res 294: 480-93.
94. Smith KP, Byron M, O'Connell BC, Tam R, et al. 2004. c-Myc localization within the nucleus: evidence for association with the PML nuclear body. J Cell Biochem 93: 1282-96.
95. Arabi A, Wu S, Ridderstråle K, Bierhoff H, et al. 2005. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol 7: 303-10.
96. Thoms HC, Loveridge CJ, Simpson J, Clipson A, et al. 2010. Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination. Cancer Res 70: 139-49.
97. Messaoudi L, Yang YG, Kinomura A, Stavreva DA, et al. 2007. Subcellular distribution of human RDM1 protein isoforms and their nucleolar accumulation in response to heat shock and proteotoxic stress. Nucleic Acids Res 35: 6571-87.
98. Song Z, Wu M. 2005. Identification of a novel nucleolar localization signal and a degradation signal in Survivin-deltaEx3: a potential link between nucleolus and protein degradation. Oncogene 24: 2723-34.
99. Li X, Zhang Y, Xie P, Piao J, et al. 2010. Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI. BMC Neurosci 11: 95.
100. Wilde I, Brack M, Winget J, Mayor T. 2011. Proteomic characterization of aggregating proteins after the inhibition of the ubiquitin proteasome system. J Proteome Res 10: 1062-72.
101. Song C, Xiao Z, Nagashima K, Li CC, et al. 2008. The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation. Toxicol Appl Pharmacol 228: 351-63.
102. Olzscha H, Schermann SM, Woerner AC, Pinkert S, et al. 2011. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144: 67-78.